1. Home
  2. PPBT vs RVSN Comparison

PPBT vs RVSN Comparison

Compare PPBT & RVSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • RVSN
  • Stock Information
  • Founded
  • PPBT 2010
  • RVSN 2016
  • Country
  • PPBT Israel
  • RVSN Israel
  • Employees
  • PPBT N/A
  • RVSN N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • RVSN
  • Sector
  • PPBT Health Care
  • RVSN
  • Exchange
  • PPBT Nasdaq
  • RVSN Nasdaq
  • Market Cap
  • PPBT 6.3M
  • RVSN 6.6M
  • IPO Year
  • PPBT N/A
  • RVSN 2022
  • Fundamental
  • Price
  • PPBT $2.40
  • RVSN $0.34
  • Analyst Decision
  • PPBT Strong Buy
  • RVSN
  • Analyst Count
  • PPBT 1
  • RVSN 0
  • Target Price
  • PPBT $33.00
  • RVSN N/A
  • AVG Volume (30 Days)
  • PPBT 23.8K
  • RVSN 584.0K
  • Earning Date
  • PPBT 08-15-2025
  • RVSN 07-07-2025
  • Dividend Yield
  • PPBT N/A
  • RVSN N/A
  • EPS Growth
  • PPBT N/A
  • RVSN N/A
  • EPS
  • PPBT N/A
  • RVSN N/A
  • Revenue
  • PPBT N/A
  • RVSN $1,300,000.00
  • Revenue This Year
  • PPBT N/A
  • RVSN $1,861.54
  • Revenue Next Year
  • PPBT N/A
  • RVSN N/A
  • P/E Ratio
  • PPBT N/A
  • RVSN N/A
  • Revenue Growth
  • PPBT N/A
  • RVSN 815.49
  • 52 Week Low
  • PPBT $2.00
  • RVSN $0.27
  • 52 Week High
  • PPBT $13.95
  • RVSN $2.72
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 47.68
  • RVSN 44.72
  • Support Level
  • PPBT $2.26
  • RVSN $0.32
  • Resistance Level
  • PPBT $2.45
  • RVSN $0.35
  • Average True Range (ATR)
  • PPBT 0.14
  • RVSN 0.03
  • MACD
  • PPBT -0.01
  • RVSN 0.00
  • Stochastic Oscillator
  • PPBT 44.12
  • RVSN 49.13

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

About RVSN Rail Vision Ltd.

Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.

Share on Social Networks: